Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eishi Baba

Showing results (51-60 of 189) with videos related to

Pageof 19
Sort By:
Advances in Therapy|February 22, 2012
Phase 2 study of modified irinotecan and bolus 5-fluorouracil/l-leucovorin in Japanese metastatic colorectal cancer patientsEishi Baba, Hiromitsu Fujishima, Akitaka Makiyama, et al.
Medicine|December 9, 2016
Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapyHitoshi Kusaba, Hozumi Kumagai, Kyoko Inadomi, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2005
In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell linesRisa Tanaka, Yasushi Takii, Yoshihiro Shibata, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancerBaoli Qin, Ken Kato, Kenji Mitsugi, et al.
Frontiers in Oncology|October 23, 2023
Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancerHirofumi Ohmura, Moe Kondo, Masato Uenomachi, et al.
Journal of Pharmaceutical Health Care and Sciences|January 30, 2018
A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factorsTetsuya Sasaki, Yasuhisa Kato, Atsushi Sato, et al.
International Journal of Clinical Oncology|October 27, 2009
Oxaliplatin-induced allergic reaction in patients with colorectal cancer in JapanYoshihiro Shibata, Hiroshi Ariyama, Eishi Baba, et al.
Cancer Science|September 2, 2022
Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancerTomoyasu Yoshihiro, Hiroshi Ariyama, Kyoko Yamaguchi, et al.
Oncology Reports|August 4, 2005
Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitroRisa Tanaka, Hiroshi Ariyama, Baoli Qin, et al.
Japanese Journal of Clinical Oncology|June 29, 2022
IMPROVE bleeding score predicts major bleeding in advanced gastrointestinal cancer patients with venous thromboembolismHitoshi Kusaba, Shohei Moriyama, Michinari Hieda, et al.
Pageof 19

Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
Advances in Therapy|February 22, 2012
Phase 2 study of modified irinotecan and bolus 5-fluorouracil/l-leucovorin in Japanese metastatic colorectal cancer patientsEishi Baba, Hiromitsu Fujishima, Akitaka Makiyama, et al.
Medicine|December 9, 2016
Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapyHitoshi Kusaba, Hozumi Kumagai, Kyoko Inadomi, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2005
In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell linesRisa Tanaka, Yasushi Takii, Yoshihiro Shibata, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancerBaoli Qin, Ken Kato, Kenji Mitsugi, et al.
Frontiers in Oncology|October 23, 2023
Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancerHirofumi Ohmura, Moe Kondo, Masato Uenomachi, et al.
Journal of Pharmaceutical Health Care and Sciences|January 30, 2018
A questionnaire survey of pharmacists regarding the clinical practice guidelines for the appropriate use of granulocyte-colony stimulating factorsTetsuya Sasaki, Yasuhisa Kato, Atsushi Sato, et al.
International Journal of Clinical Oncology|October 27, 2009
Oxaliplatin-induced allergic reaction in patients with colorectal cancer in JapanYoshihiro Shibata, Hiroshi Ariyama, Eishi Baba, et al.
Cancer Science|September 2, 2022
Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancerTomoyasu Yoshihiro, Hiroshi Ariyama, Kyoko Yamaguchi, et al.
Oncology Reports|August 4, 2005
Synergistic interaction between oxaliplatin and SN-38 in human gastric cancer cell lines in vitroRisa Tanaka, Hiroshi Ariyama, Baoli Qin, et al.
Japanese Journal of Clinical Oncology|June 29, 2022
IMPROVE bleeding score predicts major bleeding in advanced gastrointestinal cancer patients with venous thromboembolismHitoshi Kusaba, Shohei Moriyama, Michinari Hieda, et al.
Pageof 19